logo
Plus   Neg
Share
Email

Bristol-Myers Squibb To Become Limited Partner Of BioMotiv - Quick Facts

BioMotiv and Bristol-Myers Squibb (BMY) have entered a strategic partnership to develop new therapies. Bristol-Myers Squibb will become a limited partner of BioMotiv with the option to invest additional funding in selected projects. BioMotiv and Bristol-Myers will form and fund new companies to develop therapeutics in disease areas where unmet medical needs remain.

Bruce Car, Interim Head, Discovery Research, Bristol-Myers, said: "Partnering with an innovative accelerator like BioMotiv strengthens our ability to translate cutting edge, early-stage academic discoveries into new therapies for patients with serious diseases."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Delta Air Lines Inc. said Friday that it will invest $1 billion over the next decade to mitigate all greenhouse gas emissions from its global business, starting March 1, 2020. The company intends to become the first airline in the world to go carbon neutral. The airline said that over the next decade, it will spend $1 billion to drive innovation and advance clean-air travel technologies. Crown Castle International Corp. (REIT) (CCI) is currently gaining over 1% on Friday morning. Early this week, a U.S. District judge ruled in favor of Sprint and T-Mobile's long-pending $26 billion merger deal. The judge dismissed a lawsuit brought by a group of State Attorneys General. The deal is... Online furniture retailer Wayfair Inc. is cutting 550 jobs, or about 3 percent of its workforce, reports on Thursday quoted a company spokesperson as saying. The job cuts will impact about 350 employees at Wayfair's corporate headquarters in Boston. The company has more than 16,000 employees globally. Wayfair's shares tumbled 14 percent in Thursday's trading session following news of the job cuts.
Follow RTT
>